TWD 8.0
(2.17%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 472 Thousand TWD | -59.66% |
2022 | 1.17 Million TWD | 0.0% |
2021 | - TWD | -100.0% |
2020 | 331 Thousand TWD | -62.81% |
2019 | 890 Thousand TWD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 119 Thousand TWD | 0.0% |
2024 Q1 | 119 Thousand TWD | 0.0% |
2023 FY | 472 Thousand TWD | -59.66% |
2023 Q2 | 823 Thousand TWD | 0.0% |
2023 Q1 | 823 Thousand TWD | -29.66% |
2023 Q3 | 472 Thousand TWD | -42.65% |
2023 Q4 | 472 Thousand TWD | 0.0% |
2022 Q4 | 1.17 Million TWD | 0.0% |
2022 Q3 | 1.17 Million TWD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 60.65 Million TWD | 99.222% |
Level Biotechnology Inc. | 9.88 Million TWD | 95.225% |
Sagittarius Life Science Corp | 6.25 Million TWD | 92.453% |
NeoCore Technology Co., Ltd. | 33.65 Million TWD | 98.597% |
TaiMed Biologics Inc. | 521.7 Million TWD | 99.91% |
GlycoNex Incorporation | - TWD | -Infinity% |
VBI | - TWD | -Infinity% |
GeneReach Biotechnology Corp. | 97.74 Million TWD | 99.517% |
Taiwan Advance Bio-Pharmaceutical Inc. | 86.89 Million TWD | 99.457% |
Visgeneer Inc. | 114.17 Million TWD | 99.587% |
Mycenax Biotech Inc. | 569.78 Million TWD | 99.917% |
Sunmax Biotechnology Co., Ltd. | 144.77 Million TWD | 99.674% |
G&E Herbal Biotechnology Co., Ltd. | 1.29 Million TWD | 63.524% |
Medigen Vaccine Biologics Corporation | 254.35 Million TWD | 99.814% |
Enimmune corporation | 1.75 Million TWD | 73.167% |
TaiRx, Inc. | 8.96 Million TWD | 94.737% |
CHO Pharma, Inc. | - TWD | -Infinity% |
EirGenix Inc. | 436.54 Million TWD | 99.892% |
BioLASCO Taiwan Co., Ltd. | 51.43 Million TWD | 99.082% |
Sunny Pharmtech Inc. | 376.29 Million TWD | 99.875% |
Lin BioScience, Inc. | 29.02 Million TWD | 98.374% |
BioGend Therapeutics Co., Ltd. | 9.44 Million TWD | 95.001% |
Feng Chi Biotech Corp. | 8.14 Million TWD | 94.208% |
Bio Preventive Medicine Corp. | 106.2 Million TWD | 99.556% |
Lukas Biomedical Inc. | 69.9 Million TWD | 99.325% |
RBC Bioscience Corporation | 412.59 Million TWD | 99.886% |
BiOptic Inc. | 85.79 Million TWD | 99.45% |
BRIM Biotechnology, Inc. | 108 Thousand TWD | -337.037% |
Shine-On BioMedical Co.,Ltd. | - TWD | -Infinity% |
Great Novel Therapeutics Biotech & Medicals | 10.88 Million TWD | 95.662% |
Syngen Biotech Co.,Ltd. | 386.07 Million TWD | 99.878% |
Anti-Microbial Savior BioteQ Co., Ltd | - TWD | -Infinity% |
SynCore Biotechnology Co.,Ltd | - TWD | -Infinity% |
Genomics BioSci & Tech. Co.,Ltd. | 222.24 Million TWD | 99.788% |
Neith Corporation | 714 Thousand TWD | 33.894% |
Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
NaviFUS Corp. | 25.83 Million TWD | 98.173% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 366 Million TWD | 99.871% |
Sinew Pharma Inc. | - TWD | -Infinity% |
Andros Pharmaceuticals Co.,Ltd | 22.02 Million TWD | 97.857% |
Greenyn Biotechnology Co., Ltd | 55.91 Million TWD | 99.156% |
Lumosa Therapeutics Co., Ltd. | 8.11 Million TWD | 94.185% |
AP Biosciences Inc | 70.42 Million TWD | 99.33% |
Medigen Biotechnology Corp. | 449.09 Million TWD | 99.895% |
3D Global Biotech Inc. | 4.08 Million TWD | 88.437% |
Pharmosa Biopharm Inc. | 118.41 Million TWD | 99.601% |
Intech Biopharm Corporation | 970.4 Million TWD | 99.951% |
Oneness Biotech Co., Ltd. | 397.95 Million TWD | 99.881% |
Eusol Biotech Co.,Ltd. | 1.6 Million TWD | 70.61% |
TWi Biotechnology, Inc. | 5.6 Million TWD | 91.576% |
Ever Supreme Bio Technology Co., Ltd | 503 Thousand TWD | 6.163% |
TCI GENE Inc. | - TWD | -Infinity% |
MegaPro Biomedical Co., Ltd | 5.62 Million TWD | 91.613% |
Senhwa Biosciences, Inc. | 3.28 Million TWD | 85.64% |
Taiwan Bio Therapeutics Co., Ltd | 250.51 Million TWD | 99.812% |
NatureWise Biotech & Medicals Corporation | 3.26 Million TWD | 85.544% |
PharmaEngine, Inc. | 7.14 Million TWD | 93.392% |
Savior Lifetec Corporation | 257.03 Million TWD | 99.816% |
TaiGen Biopharmaceuticals Holdings Limited | 58.71 Million TWD | 99.196% |
OBI Pharma, Inc. | 439.88 Million TWD | 99.893% |
Meribank Biotech Co., Ltd | 14.81 Million TWD | 96.813% |
Acepodia, Inc. | 233.45 Million TWD | 99.798% |
Caliway Biopharmaceuticals Co., Ltd. | 11.87 Million TWD | 96.025% |